Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amnion Membrane Powder for Wound Healing
NCT03754218Phase 1Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2019
- Primary completion
- Nov 2023
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of amnion membrane powder in burn injury and skin wound (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Incidence of Donor Site Wound Closure at 4 weeks. Started Dec 2019; status: completed.
02
Drugs
amnion membrane powder
03
Conditions
burn injuryskin wound
Beyond the preview
Go deeper on NCT03754218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03754218.